308 related articles for article (PubMed ID: 23359508)
1. Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets.
Mamessier E; Pradel LC; Thibult ML; Drevet C; Zouine A; Jacquemier J; Houvenaeghel G; Bertucci F; Birnbaum D; Olive D
J Immunol; 2013 Mar; 190(5):2424-36. PubMed ID: 23359508
[TBL] [Abstract][Full Text] [Related]
2. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
3. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V
J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534
[TBL] [Abstract][Full Text] [Related]
4. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
5. Role of chemokines in the biology of natural killer cells.
Maghazachi AA
Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
[TBL] [Abstract][Full Text] [Related]
6. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG
Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499
[TBL] [Abstract][Full Text] [Related]
7. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
[TBL] [Abstract][Full Text] [Related]
8. Differential oncolytic effect of NK-enriched subsets in long-term interleukin-2 cultures.
Fuchshuber PR; Lotzová E
Lymphokine Cytokine Res; 1992 Oct; 11(5):271-6. PubMed ID: 1281676
[TBL] [Abstract][Full Text] [Related]
9. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
10. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional heterogeneity of natural killer cells from umbilical cord blood mononuclear cells.
Fan YY; Yang BY; Wu CY
Immunol Invest; 2008; 37(1):79-96. PubMed ID: 18214801
[TBL] [Abstract][Full Text] [Related]
12. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M
Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005
[TBL] [Abstract][Full Text] [Related]
13. Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs.
Fan YY; Yang BY; Wu CY
Cell Biol Int; 2008 Feb; 32(2):188-97. PubMed ID: 17920947
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
Belisle JA; Gubbels JA; Raphael CA; Migneault M; Rancourt C; Connor JP; Patankar MS
Immunology; 2007 Nov; 122(3):418-29. PubMed ID: 17617155
[TBL] [Abstract][Full Text] [Related]
15. IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion.
Huenecke S; Zimmermann SY; Kloess S; Esser R; Brinkmann A; Tramsen L; Koenig M; Erben S; Seidl C; Tonn T; Eggert A; Schramm A; Bader P; Klingebiel T; Lehrnbecher T; Passweg JR; Soerensen J; Schwabe D; Koehl U
J Immunother; 2010; 33(2):200-10. PubMed ID: 20145545
[TBL] [Abstract][Full Text] [Related]
16. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling.
Hanna J; Bechtel P; Zhai Y; Youssef F; McLachlan K; Mandelboim O
J Immunol; 2004 Dec; 173(11):6547-63. PubMed ID: 15557145
[TBL] [Abstract][Full Text] [Related]
17. Analysis of CD16+dim and CD16+bright lymphocytes--comparison of peripheral and clonal non-MHC-restricted T cells and NK cells.
Uciechowski P; Werfel T; Leo R; Gessner JE; Schubert J; Schmidt RE
Immunobiology; 1992 Jun; 185(1):28-40. PubMed ID: 1398740
[TBL] [Abstract][Full Text] [Related]
18. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.
Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C
Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training.
Suzui M; Kawai T; Kimura H; Takeda K; Yagita H; Okumura K; Shek PN; Shephard RJ
J Appl Physiol (1985); 2004 Jun; 96(6):2167-73. PubMed ID: 14752119
[TBL] [Abstract][Full Text] [Related]
20. H₂O₂ production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction.
Izawa S; Kono K; Mimura K; Kawaguchi Y; Watanabe M; Maruyama T; Fujii H
Cancer Immunol Immunother; 2011 Dec; 60(12):1801-10. PubMed ID: 21811786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
